Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

67 results about "Glucurolactone" patented technology

Process for producing glucurolactone

The invention relates to a production process for glucurono lactone, and comprises the working procedures of oxidization, hydrolization, concentration, esterification, crystallization, centrifugation, refinement, and product finishing. The invention is mainly and technically characterized in that the oxidation working procedure comprises the steps of completely adding amylum into nitric acid, insulating for above 5 hours at the temperature ranging from 37 to 43 DEG C, adding water, rising the temperature to 50-90 DEG C, and charging compressed air to react for 2 to 4 hours, so as to ensure the amylum to be fully oxidated; the concentration end point of hydrolysate is the baume degree being larger than or equal to 44 to 50, so that free water in solution is descended to the lower content to be favorable for lactonization in the next step; single esterification in the esterification working procedure is changed into multiple esterification, and the water generated in the esterification is carried over with water-carrying agent after the esterification, so that the repeated esterification is performed more thoroughly; the crystallization working procedure comprises the steps that alcohol is not required to be added for dilution, thereby ensuring a crystallization mother liquor system to be improved, and being favorable for the extraction of glucurono lactone crystallization, and also being favorable for distilling acetic acid out of parting mother liquor. The product total yield rate of the invention is enhanced to 14 to 15 percent (W/W), the consumption is reduced, the pollution is reduced, and the production cost is reduced.
Owner:王志浩

Solid effervescent mixture for the oral absorption

The invention relates to an effervescent mixture, specifically relates to a solid effervescent mixture for the oral absorption and preparation method thereof. The invention comprises the alkalic component of a mixture consisting one or more than one of alkali metal carbonate, alkali metal bicarbonate, alkaline earth metal carbonate or pearl powder; the acid component of a mixture consisting one or more than one of tartaric acid, citric acid, adipic acid, fumaric acid, maleic acid, malic acid, folic acid andacid phosphate; The medical component of a mixture consisting of one or more than one of vitamin C, glucurolactone, natural caffeine, haw extract, green tea extract, hovenia acerba extract, semen myristicae extract, Poria cocos extract, Amomum tsao-ko extract, root of kudzu vine extract, spina date seed extract, cassia twig extract, Lesser Galangal Rhizome extract, and chrysanthemum extract; the wrapper and auxiliary material of a mixture consisting one or more than one of polyethylene glycol (PEG), panthenol and glycerin monostearate. The invention comprises, by weight, 5-50% of alkalic component; 5-50% of acid component; 1-40% of medical component; 0.5-35% of wrapper; 1-10% of auxiliary material. The invention has advantages of being fast in effect, and convenient in medicine taking and carrying.
Owner:无锡健而乐医药科技有限公司

Comprehensive processing method and apparatus for mother solution in production of glucurolactone

The invention discloses a method for comprehensively treating and utilizing a mother solution in the production of glucurolactone and a device using the method. The mother solution is sent to a distillation kettle, is heated and is evaporated with a mixed solution of ester, ethanol and acetic acid till the Baume degree of the mother solution is between 40 and 50; the mixed solution is condensed through a condenser and enters a storage tank for standby; the mixed solution is sent to a neutralization and condensation kettle, is added with pure alkali or liquid alkali, is neutralized till the PH value is between 5 and 7 around, is heated and is evaporated with thin ethanol till the Baume degree is between 20 and 40; the mixed solution is cooled, crystallized and dehydrated to obtain sodium acetate; the thin ethanol enters a concentration tower, is concentrated and is supplied to the production of glucurolactone; and the residual mother solution in the distillation kettle is put to a thick mother solution tank and is directly used for producing oxalic acid. The treatment method simplifies a process, saves labor, has low cost, small energy consumption and convenient operation, can fully recycle organisms in the mother solution and can change waste to valuable.
Owner:安徽富博医药化工股份有限公司

Saline-alkali land improving agent and method by using same to improve land for rice planting

ActiveCN107840761AImprove soda-type saline-alkali landSuitable pH valueSewage/sludge fertilisersAgriculture gas emission reductionAlkali soilSugar refinery
The invention discloses a soda type saline-alkali land improving agent for rice planting, and a method by using the same to improve land and plant rice after land improving. The saline-alkali soil improving agent is prepared from the following raw materials in parts by weight: filtered mud of a sugar refinery, sulfamic acid, ferrous sulfate, aluminum sulfate, zinc sulfate and glucurolactone. The saline-alkali soil improving agent has the advantages that the soda type saline-alkali land for the rice planting is improved by the multiple components at multiple aspects, the proper pH (potential ofhydrogen) value and degree of alkalization are provided for the rice growth, the rice can be planted after the saline-alkali land is improved, and the output of the rice per mu can reach the medium and high output after the improving agent is used for two to three years; by containing the filtered mud of the sugar refinery, the sodium ions in soil sol are replaced by calcium ions in the filteredmud of the sugar refinery, so that the purpose of decreasing the degree of alkalization is realized, and the filtered mud of the sugar refinery contains about 45 to 55% of calcium carbonate and 20% oforganic matter.
Owner:内蒙古漫瀚农业科技有限公司

Preparation method of medicine for preventing and controlling liver and gall syndromes of aquatic animals

The invention relates to a preparation method of a medicine for preventing and controlling liver and gall syndromes of aquatic animals. The preparation method comprises the following steps of: 1. weighing the following raw material medicines in parts by weight: 200-400 parts of astragalus, 300-400 parts of liquorice and 100-200 parts of silybum marianum; 2. placing all the raw material medicines weighed in the step 1 in a fully-closed powder device, and mechanically extruding and knocking to crush all the weighed raw material medicines into micropowder at 50 DEG C below zero to 30 DEG C by adopting a cell wall breaking micropowder production process; and 3. weighing 10-30 parts of glucurolactone and 100-200 parts of starch in parts by weight; and mixing the weighed glucurolactone and starch with the astragalus, liquorice and silybum marianum micropowder crushed in the step 2, and finally stirring evenly to obtain the finished product. The invention has the advantages of reasonable formula, simple preparation and remarkable effect; by adopting the cell wall breaking micropowder production process, the dissolution rate of the raw material medicines is increased, and the biological availability of effective components is improved; moreover, traditional Chinese medicines and western medicines work together to achieve good prevention and control effects on liver and gall syndromes of aquatic animals without medicine residue.
Owner:TIANJIN SHENGJI GRP CO LTD

Traditional Chinese pharmaceutical composition for preventing and treating prawn encephalitozoon intestinalis, powder and preparation method thereof

ActiveCN106994172AImprove autoimmunityPrevention and treatment of intestinal microsporidiosisOrganic active ingredientsPowder deliveryRadix Astragali seu HedysariAstaxanthin
The invention relates to a traditional Chinese pharmaceutical composition for preventing and treating prawn encephalitozoon intestinalis, powder and a preparation method thereof and belongs to the technical field of traditional Chinese medicine. The traditional Chinese pharmaceutical composition is prepared from the following raw materials in parts by weight: 3 to 5 parts of lightyellow sophora root, 2 to 5 parts of radix astragali seu hedysari, 5 to 8 parts of dark malt, 10 to 15 parts of stone-like omphalia, 5 to 8 parts of radix paeoniae alba, 10 to 14 parts of cyrtomium rhizome, 2 to 5 parts of drug sweet flag rhizome, 2 to 6 parts of radix stemonae, 4 to 7 parts of fructus ulmi, 3 to 7 parts of pericarpium citri reticulatae, 10 to 12 parts of radix puerariae, 3 to 6 parts of radix codonopsis and 6 to 8 parts of radix panacis quinquefolii. The powder disclosed by the invention is prepared from the following raw materials of 90% to 95% of the traditional Chinese pharmaceutical composition, 2% to 6% of glucurolactone and 1% to 4% of astaxanthin. The preparation method disclosed by the invention utilizes nanometer low-temperature wall breaking combined with lactobacillus lactis fermentation to improve the release rate of traditional Chinese medicine and keep medicine activity, and finally, the utilization rate is improved by 5 times; meanwhile, compound enzyme is added to perform enzymolysis, so that adhesion of the encephalitozoon intestinalis is effectively reduced, and preventing and treating effects are improved.
Owner:海一(厦门)水产科技有限公司

Application of coptisine or coptisine salts in preparation of medicines for preventing and treating fatty liver damage

The invention discloses an application of coptisine or coptisine salts in the preparation of medicines for preventing and treating fatty liver damage. The pharmacological research proves that the coptisine has the effects of lowering lipid, improving lipid metabolism and alleviating the hepatic lesion caused by hepatic tissue fat accumulation and is capable of inhibiting hepatocyte triglyceride accumulation; for experimental hyperlipemia symptoms, the coptisine has the effects of obviously reducing triglyceride, cholesterol and LDL-C (low-density lipoprotein cholesterol) in blood and reducing the content of triglyceride in hepatic tissues; for fatty liver caused by the overuse of cortisol, the coptisine is capable of reducing the accumulation of triglyceride in the liver, the rise of activity of glutamic-pyruvic transaminase (GPT) and glutamic oxalacetic transaminase (GOT) and alleviating the hepatic lesion and has an excellent fatty liver prevention effect; part indexes of the coptisine are obviously superior to those of lipid reducing medicines, namely simvastatin and fenofibrate and liver protecting medicines, namely tiopronin and glucurolactone; the coptisine can be applied to clinical fatty liver diseases.
Owner:QINGDAO BAILI CAIXIN MEDICAL TECH CO LTD

Compound florfenicol preparation for aquatic animals and preparation method of compound florfenicol preparation for aquatic animals

The invention relates to the technical field of medicines and particularly discloses a compound florfenicol preparation for aquatic animals and a preparation method of the compound florfenicol preparation for the aquatic animals. The compound florfenicol preparation for the aquatic animals is prepared from, by mass, 10-20% of florfenicol, 5-15% of acetylisovaleryltylosin tartrate, 10-20% of glucurolactone, 12-20% of 2-deoxyglucose and the balance auxiliary materials. The preparation method includes manufacturing steps: drying the auxiliary materials until moisture content is 8% or below, respectively subjecting auxiliary and raw materials to grinding and screening through a 80-mesh screen, and well mixing the screened powdery auxiliary and raw materials in a mixer. The compound florfenicolpreparation for aquatic animals is easy to produce, effective in treatment of bacterial diseases of the aquatic animals, low in drug resistance and effective in protection and repair livers of the aquatic animals. By formula and process optimization, problems of poor treatment effects, high animal liver burden and the like of antibacterial medicines are solved. The compound florfenicol preparation is suitable for aquatic animals and used for treatment of various bacterial diseases.
Owner:长沙施比龙动物药业有限公司

Additive and application thereof

The invention discloses an additive and application thereof. The additive is prepared from the following components in parts by mass: 8 to 12 parts of glucurolactone and 3 to 6 parts of an acidifying agent, and the acidifying agent is prepared from the following components in parts by mass: 1.2 to 2.4 parts of formic acid, 1.2 to 2.4 parts of ammonium formate, 0.18 to 0.42 part of acetic acid, 0.18 to 0.42 part of propionic acid and 0.18 to 0.42 part of sorbic acid. The exogenous glucurolactone is used as an additive and is matched with the acidifying agent, the glucurolactone is mainly used for relieving the fatty liver, and the acidifying agent is used, so that the stability of the glucurolactone can be improved, and the content of active ingredients which play a role of the glucurolactone can be increased; and the acidifying agent can effectively reduce harmful bacteria in the feed, kill the harmful bacteria in intestinal tracts, reduce toxicity of the harmful bacteria and increase the content of beneficial bacteria in the intestinal tracts when being added to the feed for the laying hens, and by combined action of the glucurolactone and the acidifying agent, the fatty liver syndrome of the laying hens is effectively prevented and treated, and the production performance of the laying hens in the later egg laying period is improved, so that the breeding cycle of the laying hens is prolonged.
Owner:JIANGSU INST OF POULTRY SCI

A kind of compound florfenicol preparation for aquatic animals and preparation method thereof

The invention relates to the technical field of medicines and particularly discloses a compound florfenicol preparation for aquatic animals and a preparation method of the compound florfenicol preparation for the aquatic animals. The compound florfenicol preparation for the aquatic animals is prepared from, by mass, 10-20% of florfenicol, 5-15% of acetylisovaleryltylosin tartrate, 10-20% of glucurolactone, 12-20% of 2-deoxyglucose and the balance auxiliary materials. The preparation method includes manufacturing steps: drying the auxiliary materials until moisture content is 8% or below, respectively subjecting auxiliary and raw materials to grinding and screening through a 80-mesh screen, and well mixing the screened powdery auxiliary and raw materials in a mixer. The compound florfenicolpreparation for aquatic animals is easy to produce, effective in treatment of bacterial diseases of the aquatic animals, low in drug resistance and effective in protection and repair livers of the aquatic animals. By formula and process optimization, problems of poor treatment effects, high animal liver burden and the like of antibacterial medicines are solved. The compound florfenicol preparation is suitable for aquatic animals and used for treatment of various bacterial diseases.
Owner:长沙施比龙动物药业有限公司

Method for improving recovery rate of nitric acid in glucurolactone production

The invention relates to a method for improving the recovery rate of nitric acid in glucurolactone production. The method comprises the following steps: firstly, scrubbing nitric oxide gas generated by hydrolysis reaction during production of glucurolactone by a circulating scrubber tower, and condensing high-temperature water vapor in nitric oxide gas generated by hydrolysis reaction in circulating scrubbing water; secondly, mixing nitric oxide gas generated by hydrolysis reaction after circulating scrubbing with nitric oxide gas generated by oxidation reaction and then introducing air in the mixture; thirdly, inputting NO2 into 1-10-level cooling absorption towers, and controlling the spraying temperature of the circulating dilute nitric acid in the tower to be at 5-20 DEG C, wherein the NO2 and the dilute nitric acid are subjected to contact absorption to improve the concentration of the dilute nitric acid, when the concentration of the dilute nitric acid reaches 55-70%, mixing the dilute nitric acid with concentrated nitric acid to prepare the nitric acid with concentration of 72-73% for glucurolactone production; and fourthly, supplementing nitric-acid-containing steam condensate produced during circulating scrubbing of the nitric oxide gas generated by hydrolysis reaction into an acid absorption tower as a basic solution for dilute nitric acid absorption for cyclic utilization. The method can be used for reducing the total quantity of the nitric oxide gas entering the alkali absorption system, reducing the follow-up alkali absorption and consumption and reducing the cost for follow-up nitric oxide gas treatment.
Owner:HUBEI YITAI PHARMA

A traditional Chinese medicine composition, powder and preparation method for preventing and treating microsporidia in the intestinal tract of prawns

The invention relates to a traditional Chinese pharmaceutical composition for preventing and treating prawn encephalitozoon intestinalis, powder and a preparation method thereof and belongs to the technical field of traditional Chinese medicine. The traditional Chinese pharmaceutical composition is prepared from the following raw materials in parts by weight: 3 to 5 parts of lightyellow sophora root, 2 to 5 parts of radix astragali seu hedysari, 5 to 8 parts of dark malt, 10 to 15 parts of stone-like omphalia, 5 to 8 parts of radix paeoniae alba, 10 to 14 parts of cyrtomium rhizome, 2 to 5 parts of drug sweet flag rhizome, 2 to 6 parts of radix stemonae, 4 to 7 parts of fructus ulmi, 3 to 7 parts of pericarpium citri reticulatae, 10 to 12 parts of radix puerariae, 3 to 6 parts of radix codonopsis and 6 to 8 parts of radix panacis quinquefolii. The powder disclosed by the invention is prepared from the following raw materials of 90% to 95% of the traditional Chinese pharmaceutical composition, 2% to 6% of glucurolactone and 1% to 4% of astaxanthin. The preparation method disclosed by the invention utilizes nanometer low-temperature wall breaking combined with lactobacillus lactis fermentation to improve the release rate of traditional Chinese medicine and keep medicine activity, and finally, the utilization rate is improved by 5 times; meanwhile, compound enzyme is added to perform enzymolysis, so that adhesion of the encephalitozoon intestinalis is effectively reduced, and preventing and treating effects are improved.
Owner:海一(厦门)水产科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products